Commonwealth Equity Services
MIRA icon

Commonwealth Equity Services’s MIRA Pharmaceuticals MIRA Stock Holding History

Commonwealth Equity Services’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.5K Buy
35,067
+4,880
+16% +$6.12K ﹤0.01% 4221
2025
Q4 		$45.6K Hold
30,187
– – ﹤0.01% 4190
2025
Q3 		$41K Buy
30,187
+523
+2% +$759 ﹤0.01% 4174
2025
Q2 		$36K Buy
29,664
+4,117
+16% +$4.75K ﹤0.01% 4190
2025
Q1 		$25K Buy
25,547
+10,475
+69% +$11.9K ﹤0.01% 4116
2024
Q4 		$17K Buy
+15,072
New +$19.7K ﹤0.01% 4051

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $197M AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Commonwealth Equity Services's MIRA Position: Q1 2026 in Review

Commonwealth Equity Services increased its MIRA Pharmaceuticals (MIRA) stake by 16% in Q1 2026, buying an estimated $6.12K and bringing the position to 35,067 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4221.

Commonwealth Equity Services first reported a position in MIRA in Q4 2024 and has held it in 6 quarters since. The position peaked at $45.6K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Commonwealth Equity Services held 35,067 shares of MIRA Pharmaceuticals worth $37.5K as of Q1 2026.
  • Commonwealth Equity Services bought 4,880 MIRA Pharmaceuticals shares in Q1 2026, an estimated $6.12K.
  • MIRA Pharmaceuticals made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #4221 holding.
  • Commonwealth Equity Services first reported a position in MIRA Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Commonwealth Equity Services's MIRA Pharmaceuticals position peaked at $45.6K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.